BYOMass is a preclinical pharmaceutical company developing novel biologic and small molecule drugs to modulate specific members of the TGF-β superfamily, for the treatment of orphan and common diseases of high unmet medical need. Selectively targeting specific members and pathways within the TGF-β superfamily has the potential to be a meaningful class of therapeutics within oncology, inflammatory/immune, fibrotic, and metabolic diseases.
Company Details
- Employees
- 2
- Address
- Boston, Massachusetts, Us
- Industry
- Biotechnology
- Website
- http://byomasstx.com/
- Keywords
- #TGFβsuperfamily, orphandiseases, fibrosis.
- HQ
- Boston, Massachusetts
Byomass Inc. Questions
Byomass Inc.'s website is http://byomasstx.com/
Byomass Inc.'s LinkedIn profile is https://www.linkedin.com/company/byomass-inc
Byomass Inc. has
2 employees.
View email and phone details for 2
employees at Byomass Inc..
Byomass Inc.'s industry is
Biotechnology
Byomass Inc.'s top competitors are
Entrecamp,
Walk Pr,
Z Advanced Computing, Inc. (Zac),
Juvenescence®,
Prana Biosciences Inc.,
Epo,
Kingstreet,
Cytotheryx, Inc.,
Trekk Venture Partners,
Venga Ventures.
Byomass Inc.'s categories are Biotechnology
